Tag Archives: depression

Brexanolone (Zulresso) for Postpartum Depression Cleared by the DEA, Now Available

Brexanolone, to be marketed by Sage Therapeutics as Zulresso, was initially approved in March 2019, as a treatment for postpartum depression.  At that time, we were told that Zulresso would be available in June 2019. Here are a few updates. The Drug Enforcement Administration (DEA) has recommended that brexanolone be placed in schedule IV of… Read More »

Medical News Today: Can blocking a single protein tackle depression, obesity, and pain?

Depression, obesity, and chronic pain are some of the most pressing global health concerns. New research may have found a drug that could one day tackle all of these three conditions. Scientists may have identified a protein inhibitor that could tackle three conditions at once. Almost 40 percent of adults in the United States were… Read More »